Publications


Evaluation of a fast-and-frugal clinical decision algorithm (‘pathways’) on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulants;
Djulbegovic, B, Hozo, I, Lizarraga, D, Thomas, J, Barbee, M, Shah, N, Rubeor, T, Dale, J, Reiser, J & Guyatt, G 2023, , Journal of Evaluation in Clinical Practice, vol. 29, no. 1, pp. 3-12. https://doi.org/10.1111/jep.13780

Albuminuria and Heart Failure: JACC State-of-the-Art Review;
Khan, MS, Shahid, I, Anker, SD, Fonarow, GC, Fudim, M, Hall, ME, Hernandez, A, Morris, AA, Shafi, T, Weir, MR, Zannad, F, Bakris, GL & Butler, J 2023, , Journal of the American College of Cardiology, vol. 81, no. 3, pp. 270-282. https://doi.org/10.1016/j.jacc.2022.10.028

AIM2 sensors mediate immunity to Plasmodium infection in hepatocytes;
Marques-da-Silva, C, Poudel, B, Baptista, RP, Peissig, K, Hancox, LS, Shiau, JC, Pewe, LL, Shears, MJ, Kanneganti, TD, Sinnis, P, Kyle, DE, Gurung, P, Harty, JT & Kurup, SP 2023, , Proceedings of the National Academy of Sciences of the United States of America, vol. 120, no. 2, pp. e2210181120. https://doi.org/10.1073/pnas.2210181120

Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome;
Quigley, EMM, Markinson, L, Stevenson, A, Treasure, FP & Lacy, BE 2023, , Alimentary Pharmacology and Therapeutics, vol. 57, no. 1, pp. 81-93. https://doi.org/10.1111/apt.17310

Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium;
US Multicenter HCC Transplant Consortium 2023, , Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 29, no. 1, pp. 34-47. https://doi.org/10.1097/LVT.0000000000000007

Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells;
Thaiparambil, J, Amara, CS, Sen, S, Putluri, N & El-Zein, R 2023, , Cancer Medicine. https://doi.org/10.1002/cam4.5599

Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease;
Papamichael, K, Vande Casteele, N, Abraham, BP, Ritter, T, Jain, A & Cheifetz, AS 2023, , Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2022.10.037

The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome;
Sugarman, J, Maruri, A, Hamilton, DJ, Tabatabai, L, Luca, D, Cimms, T, Krolczyk, S, Roberts, MS & Carpenter, TO 2023, , Bone, vol. 166, 116598. https://doi.org/10.1016/j.bone.2022.116598

Pulmonary hypertension due to high cardiac output;
Qaiser, KN, Sahay, S & Tonelli, AR 2023, , Respiratory Medicine, vol. 206, 107034. https://doi.org/10.1016/j.rmed.2022.107034

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer;
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2023, , Cancers, vol. 15, no. 1, 81. https://doi.org/10.3390/cancers15010081